Volume 8, Issue 3 (7-2020)                   Jorjani Biomed J 2020, 8(3): 1-3 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

jafari S M. Role of Adenosine receptor in lung cancer. Jorjani Biomed J. 2020; 8 (3) :1-3
URL: http://goums.ac.ir/jorjanijournal/article-1-745-en.html
Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran/ Department of Biochemistry and Biophysics, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Abstract:   (248 Views)
Summary: Adenosine through adenosine receptor have a crucial role in biology of lung cancer. Recent study indicated adenosine receptors have a crucial role in various aspect of lung cancer from cell growth and metastasis to modulation of apoptosis and it could be considered as a potential candidate for treatment of the lung cancer.
Full-Text [PDF 382 kb]   (79 Downloads) |   |   Full-Text (HTML)  (62 Views)  
Type of Article: Letter to Editor | Subject: General medicine
Received: 2020/08/18 | Revised: 2020/11/8 | Accepted: 2020/07/31

References
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68:394-424. [view at publisher] [DOI] [Google Scholar]
2. Worley S. Lung cancer research is taking on new challenges: knowledge of tumors' molecular diversity is opening new pathways to treatment. PT. 2014;39:698.3. [view at publisher] [Google Scholar]
3. Yuan M, Huang LL, Chen JH, Wu J, Xu Q. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Tar. 2019;4:1-4.4. [view at publisher] [DOI] [Google Scholar]
4. Leone RD, Emens LA. Targeting adenosine for cancer immunotherapy. J Immunother Cancer. 2018;6:57. [view at publisher] [DOI] [Google Scholar]
5. Zhou Y, Murthy JN, Zeng D, Belardinelli L, Blackburn MR. Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. PloS one. 2010 .;5:e9224. [view at publisher] [DOI] [Google Scholar]
6. Mediavilla-Varela M, Luddy K, Noyes D, et al. Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth. Cancer Biol Ther. 2013;14:860-868. [view at publisher] [DOI] [Google Scholar]
7. Otsuki T, Kanno T, Fujita Y, et al. A3 adenosine receptor-mediated p53-dependent apoptosis in Lu-65 human lung cancer cells. Cell Physiol Biochem. 2012;30:210-220. [view at publisher] [DOI] [Google Scholar]
8. Giacomelli C, Daniele S, Romei C, Tavanti L, Neri T, Piano I, Celi A, Martini C, Trincavelli ML. The A2B adenosine receptor modulates the epithelial-mesenchymal transition through the balance of cAMP/PKA and MAPK/ERK pathway activation in human epithelial lung cells. Front Pharmacol. 2018;9:54. [view at publisher] [DOI] [Google Scholar]
9. Lan J, Lu H, Samanta D, Salman S, Lu Y, Semenza GL. Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment. Proc Natl Acad Sci U S A. 2018;115(41):E9640-8. [view at publisher] [DOI] [Google Scholar]
10. Kitabatake K, Yoshida E, Kaji T, Tsukimoto M. Involvement of adenosine A2B receptor in radiation-induced translocation of epidermal growth factor receptor and DNA damage response leading to radioresistance in human lung cancer cells. BBA Gen Subjects. 2020 ;1864(1):129457. [view at publisher] [DOI] [Google Scholar]
11. Inoue Y, Yoshimura K, Kurabe N, et al. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Oncotarget. 2017;8:8738-8751. [view at publisher] [DOI] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

© 2020 All Rights Reserved | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb